Biomerica (BMRA) Return on Capital Employed (2011 - 2026)
Biomerica (BMRA) posted Return on Capital Employed of 137.43% for Q1 2026, down 26.47% sequentially from 108.67% in Q4 2025, and down 4760.0% YoY from 2.95% in Q1 2025.
Biomerica (BMRA) Return on Capital Employed (2011 - 2026) Analysis & Trends
Biomerica has reported Return on Capital Employed for 16 years, with the latest figure at 137.43% in Q1 2026.
- Quarterly Return on Capital Employed fell 4760.0% year-over-year to 137.43% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 137.43% (down 4760.0% YoY) and the FY2025 annual result came in at 87.67%, down 2169.0% from the prior year.
- Return on Capital Employed slipped to 137.43% in Q1 2026 per BMRA's latest filing, from 108.67% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 36.4% in Q2 2022 and troughed at 137.43% in Q1 2026.
- A 5-year average of 81.76% and a median of 83.86% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2024: Return on Capital Employed soared 3007 bps in 2022, then slumped 4864 bps in 2024.
- Over 5 years, Return on Capital Employed stood at 64.25% in 2022, then grew by 8 bps to 59.11% in 2023, then plunged by 75 bps to 103.39% in 2024, then slipped by 5 bps to 108.67% in 2025, then declined by 26 bps to 137.43% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 137.43%, 108.67%, and 103.79% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -137.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -137.43% |
| Nov 30, 2025 | -108.67% |
| Aug 31, 2025 | -103.79% |
| May 31, 2025 | -104.36% |
| Feb 28, 2025 | -89.83% |
| Nov 30, 2024 | -103.39% |
| Aug 31, 2024 | -101.45% |
| May 31, 2024 | -83.86% |
| Feb 29, 2024 | -73.40% |
| Nov 30, 2023 | -59.11% |
| Aug 31, 2023 | -52.81% |
| May 31, 2023 | -76.95% |
| Feb 28, 2023 | -93.21% |
| Nov 30, 2022 | -64.25% |
| Aug 31, 2022 | -53.56% |
| May 31, 2022 | -36.40% |
| Feb 28, 2022 | -47.43% |
| Nov 30, 2021 | -77.87% |
| Aug 31, 2021 | -70.11% |
| May 31, 2021 | -66.47% |